Showing 1 to 3 of 3 results


Renal Denervation Offers Hope for Treatment-Resistant Hypertension
Doctors successfully controlled Michael Garity's dangerously high blood pressure by ablating nerves in his kidneys using renal denervation, a new treatment approved by the FDA that disrupts overactive kidney nerves, offering hope for patients with treatment-resistant hypertension.
Renal Denervation Offers Hope for Treatment-Resistant Hypertension
Doctors successfully controlled Michael Garity's dangerously high blood pressure by ablating nerves in his kidneys using renal denervation, a new treatment approved by the FDA that disrupts overactive kidney nerves, offering hope for patients with treatment-resistant hypertension.
Progress
16% Bias Score


FDA Approves Renal Denervation for Treatment-Resistant Hypertension
The FDA recently approved renal denervation, a minimally invasive procedure to treat hypertension by disrupting overactive kidney nerves, offering a new option for patients whose blood pressure remains high despite medication and lifestyle changes.
FDA Approves Renal Denervation for Treatment-Resistant Hypertension
The FDA recently approved renal denervation, a minimally invasive procedure to treat hypertension by disrupting overactive kidney nerves, offering a new option for patients whose blood pressure remains high despite medication and lifestyle changes.
Progress
32% Bias Score

Renal Denervation Shows Promise in Treating Resistant Hypertension
The FDA-approved renal denervation procedure, which disrupts overactive kidney nerves, has shown promise in treating patients with resistant hypertension, offering a new treatment option for those whose blood pressure remains high despite medication.

Renal Denervation Shows Promise in Treating Resistant Hypertension
The FDA-approved renal denervation procedure, which disrupts overactive kidney nerves, has shown promise in treating patients with resistant hypertension, offering a new treatment option for those whose blood pressure remains high despite medication.
Progress
36% Bias Score
Showing 1 to 3 of 3 results